| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c87e5f93a266af1e6ea65ee3e4d5247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e487d607c58b153207484bff663a5f63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88b36cabdbfe7ab7f6bfb5a81136e8ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcf8b26841fb3ddd106c9e7ce174ae9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8412e1eebcf050fead6e4eaff3417b92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33ee577c19aead0bfe3374502e50c833 |
| publicationDate |
2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1496053-A1 |
| titleOfInvention |
Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| abstract |
The present invention provides kappa opioid receptor agonists comprising 2-phenylbenzothiazoline derivatives. The present invention relates to kappa opioid receptor agonists comprising compounds or salts thereof having the chemical structure represented by the general formula ÄIÜ. Namely, it is important for exhibition of the kappa opioid receptor agonist actions to have an alkyl group having an amino group at a phenyl group of 2-phenylbenzothiazoline as a substituent and to have an acyl group at a nitrogen atom of 2-phenylbenzothiazoline, <CHEM> wherein R is alkyl having the amino group as the substituent; and R<1> is acyl. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1642590-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1642590-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7642274-B2 |
| priorityDate |
2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |